title: Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis.
authors.affiliation: Vasculitis and Lupus Clinic, Department of Renal Medicine, Addenbrooke's Hospital, Cambridge, UK. mwwalsh@ucalgary.ca
authors.forename: Michael
authors.initials: M
authors.lastname: Walsh
authors.forename: Marcello
authors.initials: M
authors.lastname: Tonelli
authors.forename: David
authors.initials: D
authors.lastname: Jayne
authors.forename: Braden
authors.initials: B
authors.lastname: Manns
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D015415:Biomarkers / Q000378:metabolism*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000639:trends; D012008:Recurrence; D014657:Vasculitis / Q000276:immunology* / Q000378:metabolism*
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D015415:Biomarkers